Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

114 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The British Society for Rheumatology biologics register.
Watson K, Symmons D, Griffiths I, Silman A. Watson K, et al. Ann Rheum Dis. 2005 Nov;64 Suppl 4(Suppl 4):iv42-3. doi: 10.1136/ard.2005.042499. Ann Rheum Dis. 2005. PMID: 16239385 Free PMC article. Review.
Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL, Symmons DP, Watson KD, Silman AJ; British Society for Rheumatology Biologics Register. Hyrich KL, et al. Among authors: watson kd. Arthritis Rheum. 2006 Jun;54(6):1786-94. doi: 10.1002/art.21830. Arthritis Rheum. 2006. PMID: 16736520 Free article.
Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.
Dixon WG, Watson K, Lunt M, Hyrich KL, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register. Dixon WG, et al. Arthritis Rheum. 2006 Aug;54(8):2368-76. doi: 10.1002/art.21978. Arthritis Rheum. 2006. PMID: 16868999 Free article.
Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis: results from a large UK national cohort study.
Hyrich KL, Lunt M, Watson KD, Symmons DP, Silman AJ; British Society for Rheumatology Biologics Register. Hyrich KL, et al. Among authors: watson kd. Arthritis Rheum. 2007 Jan;56(1):13-20. doi: 10.1002/art.22331. Arthritis Rheum. 2007. PMID: 17195186 Free article.
114 results